Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... Read More
Singapore, July 29 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More
U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07731711) titled 'High Intensity Magnetic Stimulation on Urge Urinary Incontinence in Postmenopausal Women' o... Read More
U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07731763) titled 'Effects of Myofascial Release Versus Dry Cupping on Pain, Muscle Length, and Functional Dis... Read More
U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07730021) titled 'A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid T... Read More